SEC 13F Intelligence

Bml Capital Management, LLC / JANX

Bml Capital Management, LLC’s Janux Therapeutics Inc Position

Does Bml Capital Management, LLC own Janux Therapeutics Inc (JANX)? Yes155.0K shares worth $2M (+1.38% of its 13F portfolio) as of Q1 2026.

Position Value
$2M
Q1 2026
Shares
155.0K
% of Portfolio
+1.38%
Quarters Held
1
currently held

Position History JANX

Reported value by quarter
Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026155.0K$2M+1.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of JANX.